Pharmaceutical Associates, Inc. (PAI) announced today the appointment of Dr. Suketu Sanghvi as Chief Scientific Officer. Dr. Sanghvi brings significant R&D experience to PAI with over 30 years in the pharmaceutical industry which have resulted in the development and launch of over 100 generic products, a dozen branded and specialty products, and numerous ANDA first-to-file applications. In his new role, Dr. Sanghvi will lead PAI’s Research and Development (R&D) efforts which are focused on oral liquid and sterile injectable products.
“We are excited to have Suketu join the PAI team,” said Kurt Orlofski, CEO of PAI. “He brings a depth in R&D expertise that will be extremely valuable for the continued growth and success of our company.”
“As PAI continues to rapidly expand our portfolio, Dr. Sanghvi’s leadership and experience across a multitude of dosage forms including injectables, suspensions, topicals and solid oral dosage will be invaluable. Under his leadership we will continue to advance a compelling portfolio of new products,” said Brandon Rockwell, Chief Operating Officer of PAI.